48,860
edits
Difference between revisions of "Neuroendocrine tumour of the pancreas"
Jump to navigation
Jump to search
Neuroendocrine tumour of the pancreas (view source)
Revision as of 19:01, 8 May 2018
, 19:01, 8 May 2018→IHC
(→IHC) |
|||
| Line 120: | Line 120: | ||
*Synaptophysin +ve. | *Synaptophysin +ve. | ||
*CD56 +ve. | *CD56 +ve. | ||
*[[PAX8]] +ve.<ref name=pmid20890270>{{Cite journal | last1 = Sangoi | first1 = AR. | last2 = Ohgami | first2 = RS. | last3 = Pai | first3 = RK. | last4 = Beck | first4 = AH. | last5 = McKenney | first5 = JK. | last6 = Pai | first6 = RK. | title = PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma. | journal = Mod Pathol | volume = 24 | issue = 3 | pages = 412-24 | month = Mar | year = 2011 | doi = 10.1038/modpathol.2010.176 | PMID = 20890270 }}</ref> | |||
Functional tumours: | Functional tumours: | ||